Oligodendrocytes are implicated in several neurological diseases. For example, in multiple sclerosis (MS), the immune system attacks the myelin sheath, leading to demyelination and impaired neural function. Damage to oligodendrocytes can result in symptoms such as muscle weakness, coordination problems, and cognitive dysfunction. Research into oligodendrocyte biology is crucial for developing therapies for demyelinating diseases.